CrushSCI.com
提供学术论文选刊润色服务
HemaSphere 期刊封面 医学
返回期刊列表

Review Cycle Records

HemaSphere

Wiley SCIE OA
2026新锐 2区2025中科院 3区2025 JCR Q1
111.3平均天数
101.5中位天数
5最短天数
251最长天数
2302025发文量

Paper Review Records

全部论文审稿周期

20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

108 天

Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long‐term results from FIL‐FLAZ12 Phase III trial

作者Rita Tavarozzi; Andrea Evangelista; Manuela Zanni; Chiara Consoli; Alessandra Tucci; Barbara Botto; Silvia Bolis; Pietro Lauzzana; Vittorio Ruggero Zilioli; Benedetta Puccini; Annalisa Arcari; Vincenzo Pavone; Gloria Margiotta‐Casaluci; Monica Tani; Federica Cavallo; Antonio Pinto; Chiara Ghiggi; Domenico Pastore; Paolo Corradini; Andrés José María Ferreri; Angelo Palmas; Caterina Patti; Francesca Re; Fabio Benedetti; Giuseppe Milone; Stefano Luminari; Elsa Pennese; Elisa Bossi; Carola Boccomini; Antonella Anastasia; Chiara Bottelli; Donato Mannina; Samantha Pozzi; Catello Califano; Luca Arcaini; Flavio Falcinelli; Giuseppe Pietrantuono; Ilaria Del Giudice; Sara Usai; Jacopo Olivieri; Filippo Gherlinzoni; Attilio Olivieri; Tommasina Perrone; Fabrizio Pomponi; Giovannino Ciccone; Umberto Vitolo; Marco Ladetto

作者单位1. Department of Translational Medicine University of Eastern Piedmont Novara Italy; 2. SCDU of Hematology AOU SS Antonio e Biagio e Cesare Arrigo Alessandria Italy; 3. Unit of Clinical Epidemiology AOU Città Della Salute E Della Scienza Di Torino and CPO Piemonte Turin Italy; 4. Department of Molecular Biotechnology and Health Sciences, Hematology Division University of Torino Turin Italy; 5. Department of Hematology Spedali Civili Brescia Italy; 6. Struttura Complessa Ematologia AOU Città della salute e della scienza di Torino Turin Italy; 7. Division of Haematology SC Ematologia Fondazione Irccs San Gerardo dei Tintori Monza Italy; 8. Division of Hematology, Clinica Ematologica, Centro Trapianti e Terapie Cellulari Carlo Melzi DISM, Azienda Ospedaliero Universitaria S. M. Misericordia Udine Italy; 9. Division of Haematology ASST Grande Ospedale Metropolitano Niguarda Milan Italy; 10. Department of Haematology University of Florence Florence Italy; 11. Division of Hematology AUSL of Piacenza Piacenza Italy; 12. Hematology Unit Ospedale Guglielmo da Saliceto Piacenza Italy; 13. SC of Hematology A. O. C. Panico‐U. O. C Ematologia e Trapianto Tricase Italy; 14. Division of Hematology AOU Maggiore della Carità di Novara Novara Piedmont Italy; 15. Hematology Unit, Department of Oncology and Hematology “Santa Maria delle Croci” Hospital Ravenna Italy; 16. Department of Hematology Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico “Fondazione G Pascale” Naples Italy; 17. IRCCS Azienda Ospedaliera Metropolitana Divisione di Ematologia e Terapie Cellulari Genova Italy; 18. Division of Hematology Ospedale Antonio Perrino Brindisi Italy; 19. Division of Hematology IRCCS Istituto Nazionale Tumori Milan Italy; 20. Lymphoma Unit IUniversity Vita‐Salute San Raffaele Milan Italy; 21. Strategic Program on Lymphomas IRCCS San Raffaele Scientific Institute Milan Italy; 22. Unità di Ematologia e Trapianto di Midollo Osseo, San Francesco Hospital Nuoro Italy; 23. SCDU of Hematology “Villa Sofia – Cervello” Hospital Palermo Italy; 24. Department of Hematology A. O. U. di Parma Parma Italy; 25. Department of Medicine, Section of Hematology and Bone Marrow Transplant Unit University of Verona Verona Italy; 26. Division of Hematology and Program for Hematopoietic Transplantation Azienda Ospedaliera Policlinico Vittorio Emanuele Catania Italy; 27. Hematology Azienda Unità Sanitaria Locale IRCCS of Reggio Emilia Reggio Emilia Italy; 28. SCDU of Hematology Presidio Ospedaliero Pescara Pescara Italy; 29. Hematology Unit Papardo Hospital Messina Messina Italy; 30. Dipartimento di Scienze Mediche e Chirurgiche Materno‐Infantili e dell'Adulto Università di Modena e Reggio Emilia Modena Italy; 31. Hematology Hospital “Andrea Tortora” Pagani Italy; 32. Department of Molecular Medicine University of Pavia Pavia Italy; 33. Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy; 34. Hematology and Bone Marrow Transplantation Azienda Ospedaliera Di Perugia Perugia Italy; 35. IRCCS CROB Referral Cancer Center of Basilicata Rionero in Vulture Italy; 36. Hematology, Department of Translational and Precision Medicine Sapienza University of Rome Rome Italy; 37. Unit of Hematology and Bone Marrow Transplant AO Brotzu ‐ Ospedale Oncologico Businco Cagliari Italy; 38. Clinica Ematologica Azienda Sanitaria Universitaria Friuli Centrale Udine Italy; 39. Division of Hematology Ca' Foncello Hospital Treviso Italy; 40. SCDU of Hematology Ospedale Regionale delle Marche Ancona Italy; 41. Department of Emergency and Organ Transplantation D. E. T. O., Hematology Section University of Bari Bari Italy; 42. Division of Hematology U.O.C. di Ematologia ‐ AULSS8 Berica Vicenza Italy; 43. Hematology IRCCS Candiolo Cancer Institute Turin Italy

PDF源文件 DOI 网页
251 天

Venetoclax plus azacitidine, low‐dose cytarabine, aclarubicin, and G‐CSF (VA‐CAG regimen) for newly diagnosed young patients with acute myeloid leukemia: A prospective, multicenter, single‐arm Phase II clinical trial

作者Xiaoping Li; Qiurong Zhang; Xiaoyan Li; Lin Liu; Yonglin Shen; Yu Li; Lihui Peng; Chaoyang Zhou; Chie Qiu; Zhongtao Yuan; Shiqian Hou; Youcheng Wang; Lihua Zhang; Jingqiong Li; Liang Zhao; Qiuyuan Tang; Zucong Chen; Jing Feng; Xuejuan Zhang; Guoxiu Bao; Kui Zhang; Renpeng Zhang; Shiqi Li; Yingnian Chen; Jianhua Rao; Yancheng Dong; Dingsong Zhang; Yueyuan Wang; Aifang Li; Xi Ye; Lei Lei; Jiao Chen; Sufen Xu; Yanling Jin; Chaoen Zheng; Yang Liang; Sanbin Wang

作者单位1. Department of Haematology 920th Hospital of Joint Logistics Support Force Kunming China; 2. Department of Haematology The First Affiliated Hospital of Dali University Dali China; 3. Department of Haematology The People's Hospital of Baoshan Baoshan China; 4. Department of Haematology and Oncology The Southern Central Hospital of Yunnan province Gejiu China; 5. Department of Haematology The People's Hospital of Chuxiong Chongxiong China; 6. Department of Haematology The Northeast Yunnan Center Hospital Zhaotong China; 7. Department of Haematology The People's Hospital of Yuxi City Yuxi China; 8. Department of Haematology and Oncology The People's Hospital of Lijiang Lijiang China; 9. Department of Haematology Xishuangbanna Dai Autonomous Prefecture People's Hospital Jinghong China; 10. Department of Haematology The People's Hospital of Dehong Prefecture Mangshi China; 11. Department of Haematology Dali Bai Autonomous Prefectue People's Hospital Dali China; 12. Department of Haematology The Second People's Hospital of Qujing Qujing China; 13. Department of Haematology The First People's Hospital of Zhaotong Zhaotong China; 14. Department of Haematology and Oncology The People's Hospital of Lincang Lincang China; 15. Department of Haematology Qujing Central Hospital of Yunnan Province Qujing China; 16. Department of Haematology and Rheumatism Immunity The People's Hospital of Puer Puer China; 17. Department of Hematological Oncology, State Key Laboratory of Oncology in South China Guangdong Provincial Clinical Research Centre for Cancer, Sun Yat‐sen University Cancer Center Guangzhou China

PDF源文件 DOI 网页
12 天

Isn't it ironic? Confessions of a pregnant, iron deficient hematologist

作者Lauren E. Merz

作者单位1. Division of Hematology/Oncology, Department of Medicine University of Michigan Ann Arbor MI USA

PDF源文件 DOI 网页
26 天

The case for targeting enhancer regions in high‐risk TCF3::HLF‐positive B‐cell acute lymphoblastic leukemia

作者Zahra Sheybani; Charles E. de Bock

作者单位1. Children's Cancer Institute Minderoo Children's Comprehensive Cancer Centre Randwick New South Wales Australia; 2. School of Clinical Medicine, Faculty of Medicine UNSW Sydney Sydney New South Wales Australia

PDF源文件 DOI 网页
78 天

Validation of the new IMS/IMWG consensus genomic staging (CGS) of high‐risk multiple myeloma (HRMM) in a contemporary cohort of 1209 patients

作者Efstathios Kastritis; Charalampos Filippatos; Maria Gavriatopoulou; Foteini Theodorakakou; Eirini Solia; Ioannis Ntanasis‐Stathopoulos; Panagiotis Malandrakis; Nikolaos Kanellias; Evangelos Eleutherakis‐Papaiakovou; Magdalini Migkou; Vasiliki Spiliopoulou; Ilias Katsadouros; Aikaterini Vlachou; Despina Fotiou; Konstantinos Giannakas; Erasmia Boutakoglou; Stavroula Giannouli; Panagiotis Tsirigotis; Asimina Papanikolaou; Evangelos Terpos; Meletios A. Dimopoulos

作者单位1. Department of Clinical Therapeutics, Alexandra General Hospital National and Kapodistrian University of Athens Athens Greece; 2. 2nd Department of Internal Medicine, “Hippokration” General Hospital National and Kapodistrian University of Athens Athens Greece; 3. 2nd Department of Internal Medicine ATTIKON General University Hospital, Hematology Division, National and Kapodistrian University of Athens Athens Greece; 4. Department of Haemopathology “Evangelismos” Hospital Athens Greece

PDF源文件 DOI 网页
83 天

First‐line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma

作者Umberto Vitolo; Lorenzo Falchi; Per‐Ola Andersson; Marcel Nijland; Fritz Offner; Sylvia Snauwaert; Jacob H. Christensen; Michael R. Clausen; Alexander Fosså; Pilar G. Prieto; Eliza A. Hawkes; Judit M. Jørgensen; Yasmin H. Karimi; Catharina Lewerin; Joost S. P. Vermaat; Björn E. Wahlin; Poliana Patah; Christopher Morehouse; Malene Risum; Zhu Li; Jennifer Marek; Joshua D. Brody

作者单位1. Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia‐IRCCS Candiolo (Turin) Piedmont Italy; 2. Lymphoma Service, Memorial Sloan Kettering Cancer Center New York New York USA; 3. Section for Hematology and Coagulation Sahlgrenska University Hospital Gothenburg Sweden; 4. Department of Hematology University Medical Center Groningen and University of Groningen Groningen Netherlands; 5. Department of Hematology Universitair Ziekenhuis Gent Ghent Belgium; 6. Department of Hematology AZ Sint‐Jan Hospital Bruges Belgium; 7. Department of Hematology Odense University Hospital Odense Denmark; 8. Department of Hematology and University of Southern Denmark Vejle Hospital Vejle Denmark; 9. Department of Oncology Oslo University Hospital Oslo Norway; 10. Department of Hematology IdiPaz, La Paz University Hospital Madrid Spain; 11. Olivia Newton John Cancer Research Institute at Austin Health Melbourne Victoria Australia; 12. Department of Haematology Aarhus University Hospital Aarhus Midtjylland Denmark; 13. Division of Hematology‐Oncology, Department of Medicine University of Michigan Ann Arbor MI USA; 14. Department of Hematology and Coagulation, Sahlgrenska University Hospital University of Gothenburg Gothenburg Götaland Sweden; 15. Department of Hematology Leiden University Medical Center Leiden Zuid‐Holland Netherlands; 16. Department of Hematology Karolinska Institutet Stockholm Stockholms län Sweden; 17. AbbVie North Chicago Illinois USA; 18. Genmab Plainsboro New Jersey USA; 19. Genmab Copenhagen Hovedstaden Denmark; 20. The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai New York New York USA

PDF源文件 DOI 网页
84 天

Therapeutic success and epidemiological failure in hematology

作者Pierre Sujobert

作者单位1. Hospices Civils de Lyon, Hôpital Lyon Sud, Service d'hématologie biologique Lyon France; 2. Faculté de médecine et de maïeutique Lyon Sud Charles Mérieux, Lymphoma Immunobiology Team, Université Claude Bernard Lyon 1 Oullins‐Pierre Bénite France

PDF源文件 DOI 网页
5 天

Shooting the messenger: Ecosystem approaches in haematology

作者Stephen P. Hibbs

作者单位1. Wolfson Institute of Population Health Queen Mary University of London London United Kingdom

PDF源文件 DOI 网页
129 天

Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi‐LMC study

作者Benjamin Podvin; Olivier Nibourel; Sandrine Hayette; Valérie Coiteux; Rathana Kim; Lucie Rigolot; Stéphanie Dulucq; Augustin Boudry; Geoffrey Pawlak; Wayne‐Corentin Lambert; Pascale Flandrin‐Gresta; Ivan Sloma; Christophe Roumier; Marie Balsat; Sandrine Loron; Chloé Li; Sandrine Geffroy; Jean‐Michel Cayuela; Françoise Huguet; François‐Xavier Mahon; Franck E. Nicolini; Delphine Réa; Claude Preudhomme; Nicolas Duployez; Catherine Roche‐Lestienne; Fi‐LMC group

作者单位1. Laboratory of Hematology CHU Lille Lille France; 2. PERSTIM Lab, CRC Lille University of Lille, Inserm Lille France; 3. Institut Bergonié, Fi‐LMC Bordeaux France; 4. Laboratory of Hematology and Molecular Biology, CHU Lyon Sud Pierre‐Bénite France; 5. Hematology Department Huriez Hospital, CHU Lille Lille France; 6. Hematology Laboratory University Hospital Saint‐Louis, AP‐HP and EA3518, Université Paris Cité Paris France; 7. Université Paris Cité, UMR 1342, Institut de Recherche Saint‐Louis, Leukemia Institute Paris Saint‐Louis Paris France; 8. Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole Toulouse France; 9. Laboratory of Hematology, University Hospital of Bordeaux, INSERM U1312 France; 10. ULR 2694 Metrics, Centre Hospitalier Universitaire de Lille Université de Lille Lille France; 11. Laboratory of Hematology, University Hospital of Brest Brest France; 12. Hematology Laboratory University Hospital of Saint‐Etienne St Etienne France; 13. Hematology and Immunology Department AP‐HP Henri Mondor Créteil France; 14. Hematology Department CHU Lyon Sud Lyon France; 15. Hematology Department Hopital National d'Instruction des Armées Percy Clamart France; 16. Hematology Department Institut Universitaire du Cancer de Toulouse Toulouse France; 17. Institut Bergonié Bordeaux, Unicancer Aquitaine France; 18. INSERM Lyon France; 19. Hematology Department Centre Léon Bérard Lyon France; 20. Adult Hematology Department Saint Louis University Hospital Paris France; 21. Genetics Medical Institute, Hopital Jeanne de Flandre Lille France

PDF源文件 DOI 网页
152 天

Passenger variants as pan‐clonal markers of pediatric AML: Implications for molecular MRD

作者Ruth Shiloh; Dana Dayan; Ifat Geron; Maor Cohen; Tamar Feuerstein; Jorge Cano‐Nistal; Nurit Gal‐Mark; Shlomit Barzilai‐Birenboim; Dafna Gaash; Michal Hameiri‐Grossman; Avraham Kahan; Jamal Mahajna; Nino Oniashvili; Hava Rosenfeld; Dan Scharf; Keren Shichrur; Elena Shinderman‐Maman; Sarah Elitzur; Yehudit Birger; Shai Izraeli; Yosef E. Maruvka

作者单位1. The Rina Zaizov Division of Pediatric Hematology‐Oncology Schneider Children's Medical Center Petah Tikva Israel; 2. Felsenstein Medical Research Center Tel Aviv University, Rabin Medical Center Petah Tikva Israel; 3. Department of Biotechnology and Food Engineering, Technion Haifa Israel; 4. Lokey Center for Life Science and Engineering, Technion Haifa Israel; 5. Department of Biotechnology, Faculty of Sciences Tel‐Hai University of Kiryat Shmona in the Galilee Kiryat Shmona Israel; 6. Gray Faculty of Medical and Health Sciences Tel Aviv University Tel Aviv Israel

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。